• 专利标题:   Use of nanomaterial comprising core material i.e. reduced metal oxide semiconductor nanomaterial as formulation for preparing medicine for treating atherosclerosis, inhibiting apoptosis of atherosclerotic cells and regulating lipid metabolism in atherosclerotic cells.
  • 专利号:   CN113827721-A
  • 发明人:   CHEN T, MA X, DAI T, WU A, REN W
  • 专利权人:   NINGBO INST MATERIALS TECHNOLOGY ENG C, CAS CNITECH CIXI BIOMEDICAL ENG INST
  • 国际专利分类:   A61K041/00, A61P009/10
  • 专利详细信息:   CN113827721-A 24 Dec 2021 A61K-041/00 202236 Chinese
  • 申请详细信息:   CN113827721-A CN10583672 23 Jun 2020
  • 优先权号:   CN10583672

▎ 摘  要

NOVELTY - Use of nanomaterial comprising core material i.e. reduced metal oxide semiconductor nanomaterial as formulation for preparing medicine for treating atherosclerosis, inhibiting apoptosis of atherosclerotic cells and regulating lipid metabolism in atherosclerotic cells USE - The nanomaterial is used as formulation for preparing medicine for treating atherosclerosis (claimed), inhibiting apoptosis of atherosclerotic cells and regulating lipid metabolism in atherosclerotic cells using thermal effect or reactive oxygen species. ADVANTAGE - The nanomaterial improves therapeutic effect on atherosclerotic plaques without causing significant cell death.